EGF antibody (PE)
Quick Overview for EGF antibody (PE) (ABIN1430671)
Target
See all EGF AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity
- Mouse
-
Predicted Reactivity
- Rat
-
Purification
- Purified by Protein A.
-
Immunogen
- Octameric MAP derived from mouse EGF
-
Isotype
- IgG
-
-
-
-
Application Notes
-
FCM: (1:20-100)
Optimal working dilution should be determined by the investigator. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- EGF (Epidermal Growth Factor (EGF))
-
Alternative Name
- Egf
-
Background
-
Synonyms: AI790464, Pro-epidermal growth factor, EGF
Background: EGF stimulates the growth of various epidermal and epithelial tissues in vivo and in vitro and of some fibroblasts in cell culture. Magnesiotropic hormone that stimulates magnesium reabsorption in the renal distal convoluted tubule via engagement of EGFR and activation of the magnesium channel TRPM6 (By similarity).
-
Gene ID
- 13645
-
UniProt
- P01132
-
Pathways
- NF-kappaB Signaling, RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
Target
-